{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:19:43Z","timestamp":1762899583430},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Basic Research Program of China","award":["973 Project 2013CB531501"],"award-info":[{"award-number":["973 Project 2013CB531501"]}]},{"name":"the State Key Project Specialized for Infectious Diseases","award":["2017ZX10202201, 2017ZX10203201-006"],"award-info":[{"award-number":["2017ZX10202201, 2017ZX10203201-006"]}]},{"name":"the TMMU Key Projects for Clinical Research","award":["2012XLC05"],"award-info":[{"award-number":["2012XLC05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12985-018-0982-y","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T12:11:04Z","timestamp":1524485464000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pretreatment microRNA levels can predict HBsAg clearance in CHB patients treated with pegylated interferon \u03b1-2a"],"prefix":"10.1186","volume":"15","author":[{"given":"Yanlin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonglan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"982_CR1","doi-asserted-by":"crossref","unstructured":"Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, Zoulim F, Tacke F. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017(67):370\u201398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"982_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1\u201398.","journal-title":"Hepatol Int"},{"key":"982_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.26041","volume":"57","author":"TC Tseng","year":"2013","unstructured":"Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Hsu CA, Kuo SF, Liu CH, Chen PJ, et al. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Hepatology. 2013;57:441\u201350.","journal-title":"Hepatology"},{"key":"982_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jhep.2014.05.044","volume":"61","author":"Q Ning","year":"2014","unstructured":"Ning Q, Han M, Sun Y, Jiang J, Tan D, Hou J, Tang H, Sheng J, Zhao M. Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial). J Hepatol. 2014;61:777\u201384.","journal-title":"J Hepatol"},{"key":"982_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.gastro.2015.09.043","volume":"150","author":"P Marcellin","year":"2016","unstructured":"Marcellin P, Ahn SH, Ma X, Caruntu FA, Tak WY, Elkashab M, Chuang W, Lim S, Tabak F, Mehta R, et al. Combination of Tenofovir Disoproxil fumarate and Peginterferon \u03b1-2a increases loss of hepatitis B surface antigen in patients with chronic hepatitis B. Gastroenterology. 2016;150:134\u201344.","journal-title":"Gastroenterology"},{"key":"982_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/liv.12244","volume":"34","author":"ZH Hou","year":"2014","unstructured":"Hou ZH, Han QJ, Zhang C, Tian ZG, Zhang J. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes. Liver Int. 2014;34:58\u201368.","journal-title":"Liver Int"},{"key":"982_CR7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3851\/IMP2401","volume":"17","author":"X Zhang","year":"2012","unstructured":"Zhang X, Chen C, Wu M, Chen L, Zhang J, Zhang X, Zhang Z, Wu J, Wang J, Chen X, et al. Plasma microRNA profile as a predictor of early virological response to interferon treatment in chronic hepatitis B patients. Antivir Ther. 2012;17:1243\u201353.","journal-title":"Antivir Ther"},{"key":"982_CR8","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1111\/j.1365-2893.2011.01443.x","volume":"18","author":"F Ji","year":"2011","unstructured":"Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat. 2011;18:e242\u201351.","journal-title":"J Viral Hepat"},{"key":"982_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","volume":"157","author":"R Dai","year":"2011","unstructured":"Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res. 2011;157:163\u201379.","journal-title":"Transl Res"},{"key":"982_CR10","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2147\/OTT.S124201","volume":"10","author":"J Xin","year":"2017","unstructured":"Xin J, Li J, Feng Y, Wang L, Zhang Y, Yang R. Downregulation of long noncoding RNA HOTAIRM1 promotes monocyte\/dendritic cell differentiation through competitively binding to endogenous miR-3960. Onco Tartets Ther. 2017;10:1307\u201315.","journal-title":"Onco Tartets Ther"},{"key":"982_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12967-014-0259-1","volume":"12","author":"C Du","year":"2014","unstructured":"Du C, Lv Z, Cao L, Ding C, Gyabaah OK, Xie H, Zhou L, Wu J, Zheng S. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. T Transl Med. 2014;12:259.","journal-title":"T Transl Med"},{"key":"982_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/cas.13201","volume":"108","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yang T, Zhang Z, Lu M, Zhao W, Zeng X, Zhang W. Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells. Cancer Sci. 2017;108:859\u201367.","journal-title":"Cancer Sci"},{"key":"982_CR13","doi-asserted-by":"crossref","first-page":"21120","DOI":"10.18632\/oncotarget.4229","volume":"6","author":"Y Wen","year":"2015","unstructured":"Wen Y, Lee W, Tan P, Yang S, Hsiao M, Lee L, Chien M. By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer. Oncotarget. 2015;6:21120\u201336.","journal-title":"Oncotarget"},{"key":"982_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcancer.2014.02.010","volume":"28","author":"L Mincheva-Nilsson","year":"2014","unstructured":"Mincheva-Nilsson L, Baranov V. Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance. Semin Cancer Biol. 2014;28:24\u201330.","journal-title":"Semin Cancer Biol"},{"key":"982_CR15","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1128\/JVI.00541-07","volume":"81","author":"H Guo","year":"2007","unstructured":"Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, Block TM, Guo JT. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-Akt signal transduction pathway. J Virol. 2007;81:10072\u201380.","journal-title":"J Virol"},{"key":"982_CR16","doi-asserted-by":"publisher","first-page":"e12709","DOI":"10.1111\/cmi.12709","volume":"19","author":"Y Lin","year":"2017","unstructured":"Lin Y, Deng W, Pang J, Kemper T, Hu J, Yin J, Zhang J, Lu M. The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R\/PI3K\/Akt\/mTOR\/ULK1 signaling-induced autophagy. Cell Microbiol. 2017;19:e12709.","journal-title":"Cell Microbiol"},{"key":"982_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3349\/ymj.2016.57.1.5","volume":"57","author":"YK Kim","year":"2016","unstructured":"Kim YK, Shin J, Nahm MH. NOD-like receptors in infection, immunity, and diseases. Yonsei Med J. 2016;57:5.","journal-title":"Yonsei Med J"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-0982-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-018-0982-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-0982-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T04:56:55Z","timestamp":1604206615000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-0982-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-0982-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients were provided the written informed consent prior to the study. The study was approved by the Ethics Committee of the Southwest Hospital of Third Military Medical University (Certificate No: 2015\u201328), meeting with the requirements of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"73"}}